Myeloma Paper of the Day, January 2nd, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, January 2nd, suggested by Robert Orlowski / Ana Gea, Ana Tobalina, Andrés Insunza, Aránzazu Bermúdez1, biopsy, cancer, Carmen
Related Articles
Independent Cancer Patients’ Voice – VOICE: Science for Patient Advocates
We are pleased to announce that the VOICE course will once again be residential and held at Barts Cancer Centre from the 31st August to…
Glucarpidase for Treatment of High-Dose Methotrexate Toxicity
Key Points. In patients with MTX-AKI, glucarpidase was associated with a higher adjusted odds of kidney recovery and faster time-to-kidney recovery.Glucarp
Tumor-Infiltrating Lymphocytes Therapy Now Available for Treating Unresectable or Metastatic Melanoma
When the FDA granted accelerated approval of tumor-infiltrating lymphocyte (TIL) treatment with lifileucel for patients with metastatic melanoma, Cleveland Clinic Cancer Institute was one of…
Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries
Nature Medicine – Estimates from the Global Dietary Database indicated that 2.2 million new type 2 diabetes and 1.2 million new cardiovascular disease cases were…
Benchmarking large language models for genomic knowledge with GeneTuring
Large language models have demonstrated great potential in biomedical research. However, their ability to serve as a knowledge base for genomic research remains unknown. We…
Treating Patients With DLBCL Who Are Not Eligible for CAR-T Therapy
A video from Remy Dulery, posted on Dec 18, 2024.
US spends $300 million bracing for bird flu
“While the risk to humans remains low, we are always preparing for any possible scenario that could arise,” HSS’s Xavier Becerra said.
A Simple Litmus Test for RFK Jr.’s Ideas
The media describes the new HHS chief as a conspiracy theorist. But how many of his ideas are actually used in Europe? More than you’d…
Glucarpidase for Treatment of High-Dose Methotrexate Toxicity
Key Points. In patients with MTX-AKI, glucarpidase was associated with a higher adjusted odds of kidney recovery and faster time-to-kidney recovery.Glucarp
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Nature – A study reporting the results of a clinical trial co-administering the GDF-15-blocking antibody visugromab with the anti-PD-1 antibody nivolumab demonstrates that neutralizing GDF-15…
